Informative Insight
Most Common Risks
While EECP therapy is generally considered safe, there are some potential risks and side effects that individuals may experience. The most common risks associated with EECP include:
- Skin Irritation: The cuffs used during EECP therapy may cause mild skin irritation or bruising at the site of application. This is typically temporary and resolves on its own after treatment.
- Discomfort: Some individuals may experience discomfort during EECP therapy, particularly around cuff placement areas. Adjustments can be made to the cuff pressure to minimise discomfort.
- Headache: In some cases, individuals may experience headaches during or after EECP therapy sessions. These headaches are usually mild and transient but should be reported to healthcare providers if persistent or severe.
- Dizziness or Lightheadedness: Changes in blood flow during EECP therapy may occasionally cause feelings of dizziness or lightheadedness. Individuals should be monitored closely after treatment to prevent falls or injuries.
- Fatigue: Some individuals may experience fatigue or tiredness following EECP therapy sessions, particularly during the initial stages of treatment. This fatigue typically resolves with rest and does not persist long-term.
- Musculoskeletal Discomfort: Individuals may experience musculoskeletal discomfort, such as leg or back ache, during or after EECP therapy sessions. This discomfort is usually mild and temporary but should be reported to healthcare providers if persistent or severe.
- Potential for Blood Pressure Changes: EECP therapy involves inflation and deflation of cuffs on the legs to enhance blood flow to the heart. This may cause fluctuations in blood pressure, particularly in individuals with pre-existing cardiovascular conditions or hypertension. Blood pressure should be monitored before and after treatment.
Serious complications from EECP therapy are rare and most individuals tolerate the treatment well. Healthcare providers carefully assess each patient’s medical history and overall health status to ensure the safety and effectiveness of EECP therapy. Any concerns or adverse reactions experienced during EECP therapy should be promptly reported to healthcare providers for evaluation and management.